BRCA-1 and BRCA-2 (Breast Cancer Gene 1 and 2) Tests

DNA is first extracted from the white blood cells in your sample. Your genetic code is the same in most of the cells in your body, so this is simply an easy route into exploring your genetic code. This is why a cheek swab or spit sample can also sometimes be used. The two genes BRCA-1 and BRCA-2 – which are located in different parts of the genetic code are then examined in detail to look for differences from the usual ‘sequence’ of chemicals along the code. A difference that alters the message this genetic code sends to the body is often known as a ‘mutation’. Different mutations in these genes in different families have been associated with the development of breast or ovarian cancer.

Individuals with a strong family history of breast cancer or ovarian cancer may want to know if they have an inherited tendency to these cancers. Sometimes a very young onset of breast cancer may also indicate a likely BRCA1/2 gene mutation. For example a woman diagnosed with a triple negative breast cancer in her early 30s may have a BRCA-1 gene mutation even if she does not have an obvious family history of cancer.

Note: the most useful prediction of risk from a BRCA1/2 test in an unaffected person is when a BRCA1/2 mutation has already been found in a relative with breast or ovarian cancer. Without this information, a negative BRCA1/2 test result is often not very informative. There are therefore two types of BRCA1/2 testing; ‘diagnostic’ and ‘predictive’ testing.

Diagnostic BRCA1/2 testing. This test is done in someone who has had a breast or ovarian cancer, usually in the context of a strong family history. It can give you information about chances of further cancers and can provide family members with the information to have a predictive test.

Predictive BRCA1/2 testing. This test is done in an unaffected relative of someone who is known to have a BRCA1/2 gene mutation. If you are a child or sibling of this person there will usually be a 50:50 (1 in 2 or 50% chance) that you have, or have not, inherited the mutation.

Such testing may be useful to help you decide whether to take steps that may prevent breast or ovarian cancer from developing, or may pick it up at an early and more treatable stage. There are a complex range of options available, ranging from more frequent mammograms to surgical removal of the organs at risk and you should discuss these in detail with a clinical genetics professional before deciding whether testing would be helpful or right for you. Your GP can refer you to your local clinical genetics service. (see "Is there anything else I should know?" below).

Since there are hundreds of possible mutations of BRCA genes, test results must be interpreted by taking into account a person’s personal and family history. A genetic health professional should explain the meaning of the results and offer advice to the individual and to other family members about options for decreasing risk. Such advice should be offered both before testing takes place and after receiving test results.

Your test results can affect other family members. When one member of a family is tested for BRCA mutations, issues often arise about how to share this information with other family members. Most people will want to help their family members, and may indeed only ask for testing in order to do so, but sometimes you may have lost touch with family members to whom the result may be relevant, or find it too difficult to tell them yourself. Your local clinical genetic service will be able to help you with this.

If the BRCA test is positive, we consider you to be at increased risk of developing breast and or ovarian cancer. You will have a detailed discussion with a health professional about the latest evidence for certain check-ups (e.g. mammography, MRI scans) or preventative options such as surgical removal of the ovaries or breasts.